Octopus Ventures
Oliver sits in the Octopus Ventures bio team, where he’s excited to work with entrepreneurs changing people’s lives in healthcare and beyond.
He joins Octopus Ventures from a role in the family office of Jonathan Milner (Founder CEO of Abcam) one of the UK’s most successful biotech entrepreneurs, where he supported and backed early-stage companies working in the bioscience space.
Oliver’s professional experience is underpinned by a background in biomedical science and biochemistry, coupled with commercial execution of complex biotechnologies and business models. He’s worked in biologics drug discovery, gene editing tools, breath diagnostics, and digital prediction and mitigation tools for bipolar patients.
This person is not in the org chart
This person is not in any offices
Octopus Ventures
15 followers
Octopus Ventures helps pioneers change the world. The pioneers they back dare to reimagine the future of health, money and deep tech. With £1.2 billion under management, Octopus Ventures is one of the largest VCs in Europe. Their typical investment is from £1 million for Seed to £10 million for Series B and they can follow their investment from a few hundred thousand right up to £25 million. Their team is based in London and New York with Venture Partners in San Francisco, Singapore and China.